Subgroup analysis of ECOG2 patients from ROMANA 2: A phase III study of anamorelin in NSCLC patients with cachexia.

Citation

• Abernethy, A. P., Currow, D. C., Gleich, L. L., Yan, Y., Friend, J., & Temel, J. S. (2014). Subgroup analysis of ECOG2 patients from ROMANA 2: A phase III study of anamorelin in NSCLC patients with cachexia.. Journal of Clinical Oncology, 32(31_suppl), 6. doi:10.1200/jco.2014.32.31_suppl.6

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.31_suppl.6

Web Of Science Accession Number

Start Page

• 6

End Page

• 6

Volume

• 32

Issue

• 31_suppl

Place Of Publication

Abstract

UOW Authors

•   Currow, David

Publication Date

• 2014

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Abernethy, A. P., Currow, D. C., Gleich, L. L., Yan, Y., Friend, J., & Temel, J. S. (2014). Subgroup analysis of ECOG2 patients from ROMANA 2: A phase III study of anamorelin in NSCLC patients with cachexia.. Journal of Clinical Oncology, 32(31_suppl), 6. doi:10.1200/jco.2014.32.31_suppl.6

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.31_suppl.6

Web Of Science Accession Number

Start Page

• 6

End Page

• 6

Volume

• 32

Issue

• 31_suppl

Place Of Publication